A new, noninvasive screening for Down syndrome could in the future provide detection early enough for treatment to improve babies' cognitive function in the womb, according to a Tufts University neonatal genetics expert.
The screening would allow some women with high-risk pregnancies to avoid amniocentesis as well, said Diana Bianchi, executive director of Tufts Medical Center's Mother-Infant Research Institute.